Showing results (101-110 of 113) with videos related to

Sort By:
Pageof 12
Langenbeck'S Archives of Surgery|October 17, 1998
Growth inhibition of pancreatic tumor cells by modified antisense oligodeoxynucleotidesA Fiedler, C Knorre, Y Franke, et al.
British Journal of Cancer|December 14, 2006
Complementary effects of HDAC inhibitor 4-PB on gap junction communication and cellular export mechanisms support restoration of chemosensitivity of PDAC cellsO Ammerpohl, A Trauzold, B Schniewind, et al.
Oncogene|July 21, 2001
CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cellsA Trauzold, H Wermann, A Arlt, et al.
Oncogene|October 18, 2006
Periostin promotes invasiveness and resistance of pancreatic cancer cells to hypoxia-induced cell death: role of the beta4 integrin and the PI3k pathwayP Baril, R Gangeswaran, P C Mahon, et al.
International Journal of Cancer|December 18, 2001
Human endostatin inhibits growth of human non-small-cell lung cancer in a murine xenotransplant modelA S Boehle, R Kurdow, M Schulze, et al.
Oncogene|September 8, 2009
Increased proteasome subunit protein expression and proteasome activity in colon cancer relate to an enhanced activation of nuclear factor E2-related factor 2 (Nrf2)A Arlt, I Bauer, C Schafmayer, et al.
Virchows Archiv : an International Journal of Pathology|January 15, 2002
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4P S Moore, B Sipos, S Orlandini, et al.
Gut|January 22, 2008
Anti-apoptotic and growth-stimulatory functions of CK1 delta and epsilon in ductal adenocarcinoma of the pancreas are inhibited by IC261 in vitro and in vivoC Brockschmidt, H Hirner, N Huber, et al.
British Journal of Cancer|October 16, 2008
Co-expression of KLK6 and KLK10 as prognostic factors for survival in pancreatic ductal adenocarcinomaF Rückert, M Hennig, C D Petraki, et al.
European Journal of Cancer (Oxford, England : 1990)|January 18, 2011
TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancerF A Castro, A Försti, S Buch, et al.
Pageof 12